Skip to main content
. Author manuscript; available in PMC: 2013 Sep 12.
Published in final edited form as: European J Clin Med Oncol. 2012 Jul;4(2):25–32.

Table 1.

Survival results from selected series using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy to treat malignant peritoneal mesothelioma.

Study n= Median OS
(months)		 Survival
3-year 5-year
Blackham 2010[10] 38 41 56% 17%
Brigand 2006[11] 15 36 43% 29%
Baratti 2010[12] 83 44 * 50%
Feldman 2003[13] 49 92 59% 59%
Yan 2006[14] 100 52 55% 46%
Kluger 2010[15] 47 55 62% 49%
Tudor 2010[16] 20 30 46% *
Yan 2009[19] 401 53 60% 47%
*

not reported